• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常儿童和生长迟缓儿童的24小时骨钙素、I型前胶原羧基末端前肽及III型前胶原氨基末端前肽节律

Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.

作者信息

Saggese G, Baroncelli G I, Bertelloni S, Cinquanta L, DiNero G

机构信息

Department of Pediatrics, University of Pisa, Italy.

出版信息

Pediatr Res. 1994 Apr;35(4 Pt 1):409-15.

PMID:8047377
Abstract

The relationships between spontaneous variations in serum 24-h osteocalcin (OC), carboxyterminal propeptide of type I procollagen (PICP), and aminoterminal propeptide of type III procollagen (PIIINP) concentrations and GH secretion, measured as GH response to provocative pharmacologic stimuli and spontaneous GH secretion during 24 h, were evaluated in prepubertal normal children and in GH-deficient and GH-secreting short normal children (SNC). All the subjects showed a circadian rhythm in smoothed 24-h OC and PICP mean data with higher nocturnal values in comparison with diurnal values. Conversely, serum PIINP concentrations did not vary throughout the day. In children with classic GH deficiency and nonclassic GH deficiency, mean 24-h serum levels and smoothed 24-h mean data for OC, PICP, and PIIINP were significantly reduced (p < 0.001) with respect to age-matched controls. SNC showed mean 24-h OC concentrations similar (p = NS) to those we found in age-matched controls, but they had significantly lower (p < 0.001) diurnal 12-h mean data in comparison with controls. SNC also showed both 24-h PICP and PIIINP mean data and smoothed 24-h PICP and PIIINP mean data significantly lower (from p < 0.02 to p < 0.001) at all the time points of measurement in comparison with controls. Twenty-four-hour PICP and PIIINP mean data were positively related to spontaneous 24-h GH concentrations (r = 0.77, p < 0.005 and r = 0.69, p < 0.005, respectively) and growth velocity (r = 0.85, p < 0.005, and r = 0.70, p < 0.005, respectively), whereas 24-h OC mean data were not.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在青春期前正常儿童、生长激素缺乏儿童以及生长激素分泌型身材矮小正常儿童(SNC)中,评估了血清24小时骨钙素(OC)、I型前胶原羧基末端前肽(PICP)和III型前胶原氨基末端前肽(PIIINP)浓度的自发变化与生长激素(GH)分泌之间的关系,其中GH分泌通过GH对刺激性药物刺激的反应以及24小时内的自发GH分泌来衡量。所有受试者的24小时OC和PICP平均数据经平滑处理后呈现昼夜节律,夜间值高于日间值。相反,血清PIIINP浓度全天无变化。与年龄匹配的对照组相比,经典型生长激素缺乏和非经典型生长激素缺乏儿童的24小时血清平均水平以及OC、PICP和PIIINP的24小时平滑平均数据均显著降低(p < 0.001)。SNC的24小时OC平均浓度与我们在年龄匹配对照组中发现的浓度相似(p = 无显著性差异),但其日间12小时平均数据与对照组相比显著更低(p < 0.001)。SNC在所有测量时间点的24小时PICP和PIIINP平均数据以及24小时PICP和PIIINP平滑平均数据与对照组相比也显著更低(从p < 0.02到p < 0.001)。24小时PICP和PIIINP平均数据与24小时自发GH浓度呈正相关(分别为r = 0.77,p < 0.005和r = 0.69,p < 0.005)以及生长速度呈正相关(分别为r = 0.85,p < 0.005和r = 0.70,p < 0.005),而24小时OC平均数据则不然。(摘要截断于250字)

相似文献

1
Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.正常儿童和生长迟缓儿童的24小时骨钙素、I型前胶原羧基末端前肽及III型前胶原氨基末端前肽节律
Pediatr Res. 1994 Apr;35(4 Pt 1):409-15.
2
Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation.生长发育迟缓儿童血清I型前胶原羧基末端前肽和III型前胶原氨基末端前肽水平
Mater Med Pol. 1994 Apr-Jun;26(2):55-8.
3
Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.肢端肥大症或库欣综合征中骨与胶原蛋白转换的生化标志物。
Horm Metab Res. 1994 May;26(5):234-7. doi: 10.1055/s-2007-1001672.
4
[Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].生长激素/胰岛素样生长因子-I缺乏对儿童和成人生长激素缺乏患者骨与胶原转换的影响
Minerva Endocrinol. 1995 Jun;20(2):135-40.
5
Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone.接受持续性非卧床腹膜透析治疗患者的I型前胶原前肽:其与骨组织学、骨钙素及甲状旁腺激素的关系
Nephrol Dial Transplant. 1995 Oct;10(10):1912-7.
6
24-h profile of serum osteocalcin in growth hormone (GH) deficient patients with and without GH treatment.生长激素(GH)缺乏患者在接受和未接受GH治疗时血清骨钙素的24小时变化情况。
Growth Regul. 1991 Dec;1(4):153-9.
7
Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age.人I型胶原羧基末端前肽和吡啶交联物作为1至18个月婴儿骨骼生长的标志物。
J Bone Miner Res. 1995 Jun;10(6):849-53. doi: 10.1002/jbmr.5650100604.
8
Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
J Clin Endocrinol Metab. 1988 Dec;67(6):1244-9. doi: 10.1210/jcem-67-6-1244.
9
Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism.甲状腺功能亢进症患者血清1型胶原羧基末端前肽(PICP)水平升高。
Horm Metab Res. 1994 Jul;26(7):334-7. doi: 10.1055/s-2007-1001698.
10
[The correlation between blood concentrations of somatomedin C and the auxological characteristics in short-stature subjects].[生长介素C血浓度与身材矮小受试者体格特征之间的相关性]
Minerva Pediatr. 1991 Sep;43(9):549-56.

引用本文的文献

1
Circulating Aminoterminal Propeptide of Type III Procollagen as a Biomarker of Cardiovascular Events in Patients Undergoing Hemodialysis.循环型 III 型前胶原氨基端肽作为血液透析患者心血管事件的生物标志物。
J Atheroscler Thromb. 2019 Apr 1;26(4):340-350. doi: 10.5551/jat.45138. Epub 2018 Aug 15.
2
Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0-18 years.中欧0至18岁健康人群骨钙素和I型前胶原N端前肽血浆水平的参考值
Osteoporos Int. 2014 Feb;25(2):729-36. doi: 10.1007/s00198-013-2485-4. Epub 2013 Aug 22.
3
Growth hormone is positively associated with surrogate markers of bone turnover during puberty.
生长激素与青春期骨转换的替代标志物呈正相关。
Clin Endocrinol (Oxf). 2011 Oct;75(4):482-8. doi: 10.1111/j.1365-2265.2011.04088.x.
4
Osteoporosis in children and adolescents: etiology and management.儿童和青少年骨质疏松症:病因与管理
Paediatr Drugs. 2005;7(5):295-323. doi: 10.2165/00148581-200507050-00003.